These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8821310)

  • 1. Depression-related cognitive impairment: possibilities for its pharmacological treatment.
    Mitchell AJ; Dening TR
    J Affect Disord; 1996 Jan; 36(3-4):79-87. PubMed ID: 8821310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depressed dementia or demented depression].
    Azorin JM
    Encephale; 1994 Jun; 20 Spec No 2():281-4. PubMed ID: 8088247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic indications in symptomatic cognitive and psychopathological disorders in multiple sclerosis].
    Lebrun C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1085-90. PubMed ID: 11787341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent reversal of abnormal DSTs after different antidepressant therapies in a patient with dementia.
    Wamboldt MZ; Kalin NH; Weiler SJ
    Am J Psychiatry; 1985 Jan; 142(1):100-3. PubMed ID: 3966566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep deprivation as a diagnostic instrument.
    Williams CJ; Yeomans JD; Coughlan AK
    Br J Psychiatry; 1994 Apr; 164(4):554-6. PubMed ID: 8038950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy and other treatments for elderly patients with depression.
    Small GW
    J Clin Psychiatry; 2010 Jan; 71(1):e03. PubMed ID: 20129001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM; Sekula LK; Rubin RT
    Biol Psychiatry; 1997 Jul; 42(2):85-9. PubMed ID: 9209724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of cognitive impairment and depression in geriatric outpatients.
    Reifler BV; Larson E; Hanley R
    Am J Psychiatry; 1982 May; 139(5):623-6. PubMed ID: 7072849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression in later life: an overview with treatment recommendations.
    Ellison JM; Kyomen HH; Harper DG
    Psychiatr Clin North Am; 2012 Mar; 35(1):203-29. PubMed ID: 22370499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
    Maric NP; Adzic M
    Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in cognitive impairment.
    Pellegrino LD; Peters ME; Lyketsos CG; Marano CM
    Curr Psychiatry Rep; 2013 Sep; 15(9):384. PubMed ID: 23933974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring melancholia in the classification of mood disorders.
    Taylor MA; Fink M
    J Affect Disord; 2008 Jan; 105(1-3):1-14. PubMed ID: 17659352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR; Nemeroff CB
    J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review.
    McLennan SN; Mathias JL
    Int J Geriatr Psychiatry; 2010 Oct; 25(10):933-44. PubMed ID: 20872927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive performance in patients recovering from depression.
    Kuny S; Stassen HH
    Psychopathology; 1995; 28(4):190-207. PubMed ID: 7480575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression.
    Siegel B; Gurevich D; Oxenkrug GF
    Biol Psychiatry; 1989 Jan; 25(2):229-34. PubMed ID: 2930804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.